rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Peter Kies

CFO

Company insider

Files Form 4 as: CFO, Inovio Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
177
Buys
5
Sells
10
Bought
$83K
Sold
$3.0M
Companies
1
Companies where not an officer
0
First trade
8 Mar 2006
Last trade
20 May 2026
Last filed
21 May 2026

Companies traded

Where they are an officer
INO Inovio PharmaceuticalsOfficer · Biotechnology · last 20 May 20265 buys · 10 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 May 2026filed 21 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code M—8,700filing
20 May 2026filed 21 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code F$5,7664,688 at $1.23filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—8,700 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—8,700 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—39,760 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—32,480 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—39,760 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—32,480 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code M—8,700filing
20 May 2026filed 21 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code F$5,7664,688 at $1.23filing
15 May 2026filed 18 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code M—4,771filing
15 May 2026filed 18 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code F$3,3422,571 at $1.30filing
15 May 2026filed 18 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—4,771 at $0.00filing
15 May 2026filed 18 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—4,771 at $0.00filing
15 May 2026filed 18 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code M—4,771filing
15 May 2026filed 18 May 2026INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code F$3,3422,571 at $1.30filing
4 Mar 2026filed 5 Mar 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—31,240 at $0.00filing
4 Mar 2026filed 5 Mar 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—25,520 at $0.00filing
4 Mar 2026filed 5 Mar 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—31,240 at $0.00filing
4 Mar 2026filed 5 Mar 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—25,520 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care15

Buys in green, sells in red, by the company’s sector.

Related people

Wendy L. YarnoDirector · Director at Inovio Pharmaceuticals, filing Form 4 there in the last year
Simon X. BenitoDirector · Director at Inovio Pharmaceuticals, filing Form 4 there in the last year
Lota S. ZothDirector · Director at Inovio Pharmaceuticals, filing Form 4 there in the last year
Jay ShepardDirector · Director at Inovio Pharmaceuticals, filing Form 4 there in the last year
David B. WeinerDirector · Director at Inovio Pharmaceuticals, filing Form 4 there in the last year